公司概覽
業務類別 Biotechnology
業務概覽 Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
公司地址 500 Boylston Street, Suite 1350, Boston, MA, USA, 02116
電話號碼 +1 617 655-6580
傳真號碼 --
公司網頁 https://www.vorbio.com
員工數量 76
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Sandesh Mahatme, L.L.M. Chief Financial Officer, Chief Business Officer and Principal Accounting Officer 美元 217.85K 27/04/2026
Dr. Jean-Paul Kress, M.D. Chief Executive Officer, President and Chairman of the Board 美元 344.62K 27/04/2026
Dr. Qing Zuraw Chief Development Officer 美元 243.39K 22/07/2025
Dr. Jeremy Brett Sokolove, M.D. Chief Medical Officer -- 27/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Daniella Beckman Lead Independent Director 27/04/2026
Dr. David Zaccardelli, Pharm.D. Independent Director 07/07/2026
Dr. Jean-Paul Kress, M.D. Chief Executive Officer, President and Chairman of the Board 27/04/2026
Mr. Alexander G. Cumbo Independent Director 27/04/2026
Dr. Fouad Namouni, M.D. Independent Director 27/04/2026
Dr. Michel Detheux, PhD Independent Director 27/04/2026
Mr. Wouter Joustra Independent Director 27/04/2026
Mr. Erez Kalir Independent Director 27/04/2026
 
所屬ETF (更新日期: 07/11/2026 04:12)
代號 名稱 佔比% ▼ 持有日期
RESMColumbia Research Enhanced Small Cap ETF0.0002%31/10/2026
HDGProShares Hedge Replication0.0001%30/10/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%30/10/2026
GUGGuggenheim Active Allocation Fund0.00002%31/08/2026
  1    2   3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.